Nuclear LC3-positive puncta in stressed cells do not represent autophagosomes.

This letter points out an important potential artifact when using immunolabeling techniques with confocal microscopy to identify autophagosomes. Our laboratory has been investigating autophagy induced by varicella-zoster virus (VZV), a human herpesvirus. Although closely related to herpes simplex virus type 1 (HSV-1), VZV lacks the inhibitors of autophagy harbored within the HSV genome (1), (2), (3). Therefore, autophagy is abundant after VZV infection (4), (5), (6). Many of our studies have relied upon autophagosome quantitation to gauge the level of autophagy under varying conditions of infection (7). For these assays, we have enumerated autophagosomes (puncta) in the cytoplasm after immunolabeling with commercial LC3 antibody reagents (7). Depending on the conditions, we occasionally noticed what appeared to be puncta in the nuclei of the infected cells. In two recent autophagy articles (8), (9), other investigators had identified LC3-positive puncta in the nuclei of their stressed cells. They have implied that these LC3-positive puncta may be related to autophagy. Based on our extensive observations investigating VZV-induced autophagy, we postulate that these nuclear puncta are not related to autophagosome production, but instead are related to the antibody reagent and other experimental conditions under which the microscopy experiment is carried out. Based on prior autophagy experiments in our laboratory, we first postulated that different anti-LC3 antibodies led to different levels of nuclear LC3 staining. The panels of Figure 1 illustrate the main differences between using a rabbit monoclonal antibody (Epitomics #2057-1) versus a rabbit polyclonal antibody (Santa Cruz #sc-28266) in different cell lines. In immortalized human keratinocytes (TERT-HFK), both uninfected and VZV-infected cells were labeled with anti-LC3 antibodies, but there was a much greater amount of nuclear LC3 staining with the rabbit polyclonal anti-LC3 reagent (compare panels A and B). Panel D demonstrates that VZV IE62 immunoreactivity (red), an abundant viral protein, was present in panel B. Figure 1 Effects of antibody choice and permeabilization on nuclear LC3 immunoreactivity. (A–D) TERT-HFK cells, uninfected (A&C) or virus-infected (B&D), were permeabilized with 0.05% Triton X-100 and labeled with either Epitomics rabbit ... Panels E and F of Figure 1 show similar results in melanoma cells (4). Panel E shows syncytia cytopathology induced by VZV infection. Interestingly, nuclei (blue color) within the syncytia did not show LC3 staining after immunolabeling with the rabbit monoclonal antibody (E), although cytoplasmic puncta were easily seen. In contrast, immunolabeling with the rabbit polyclonal antibody caused prominent nuclear LC3 staining, as noted by the green puncta within the blue nuclei (F). Similar nuclear LC3 patterns were also seen in infected MRC-5 fibroblasts after immunolabeling with a polyclonal reagent (not shown). In short, nuclear puncta were more easily seen with polyclonal anti-LC3 reagents, regardless of the infected cell substrate. We next postulated that the conditions for permeabilization of the cells before immunolabeling were very important to the level of nuclear LC3 staining. All articles cited above have used Triton X-100 for permeabilization. In previous experiments, we have used Triton concentrations ranging from 0.02% to 0.1% for one hour at room temperature (RT), to permeabilize cells before immunolabeling with LC3 antibody. In the experiment shown in Figure 1 (G–I), infected cells were fixed with 2% paraformaldehyde and permeabilized with 0.02% (G), 0.05% (H) or 0.1% (H) Triton X-100, then immunolabeled with the rabbit polyclonal antibody against LC3. As the amount of Triton X-100 was increased, more nuclei contained LC3 staining. Note in particular that almost every blue nucleus in panel I contained green puncta. This effect had been observed in many different experiments in this laboratory, using different cell types and conditions of infection. We also observed that some nuclear puncta were larger than typically seen in the cytoplasm of VZV-infected cells, namely, true cytoplasmic puncta are 590 nm± 240 nm (10) whereas some nuclear puncta were >1000 nm in diameter. After observing the above differences between cytoplasmic and nuclear puncta, we postulated that the nuclear puncta were not typical double-membraned autophagosomes. Since our laboratory has used transmission electron microscopy (TEM) to examine virus-infected cells for many years, we have a large archive of micrographs. We have already documented cytoplasmic autophagosomes by TEM in an earlier paper (5). For this report, we re-examined over 70 micrographs to look for any structures that resembled autophagosomes within the nuclei of uninfected or infected cells (Figure 2). In virus-infected monolayers during later timepoints (11), many viral capsids were seen in the nuclei; capsids measure 75–100 nm in diameter (5). Since autophagosomes typically are 4–6 fold larger, we should be able to easily identify these structures, if they were present in the nuclei of these cells (Figure 2, E–H). Note the diameter of a virion in a cytoplasmic vacuole as another size control (Figure 2, circled in H). However, we found no double-membraned structures within nuclei (Figure 2). We also examined nuclear preparations from uninfected MRC-5 fibroblasts for the presence of structures that resembled autophagosomes. As seen in representative TEM images in Figure 2 (A–D), no double-membraned structures were found in uninfected nuclei. Therefore, punctate LC3 staining within nuclei of cells was not due to the LC3-II embedded in the membrane of autophagosomes or an organelle resembling an autophagosome. Figure 2 Absence of double-membraned autophagosomal structures in electron micrographs of nuclei of uninfected and virus-infected cells. (A–D) Nuclei isolated from uninfected cells showed no double-membraned structures resembling autophagosomes when examined ... We were intrigued when we read two recent autophagy papers in which the authors had observed what were called nuclear puncta identified by various anti-LC3 antibody reagents (8), (9). The authors were uncertain as to their function but speculated that the nuclear puncta may be related to autophagy. We know of no reason why our data about VZV-induced autophagy should not be applicable broadly. In particular, viral capsids in the nucleus provide a valuable marker for any structures >100 nm. Yet we see no structures compatible in size with autophagosomes in nuclei. Based on data acquired in our VZV-induced autophagy system, therefore, we postulate that these nuclear puncta are not related to autophagosome production. Instead, we conclude that a likely explanation for nuclear puncta is the formation of LC3 aggregates within the nuclei and their detection by the primary anti-LC3 antibody reagent (12). LC3-II protein is easily detectable in the nucleus (13). Earlier studies of direct precipitation of antigen by antibody by this laboratory and others demonstrate that aggregates are readily bound by polyclonal antisera (14). Further, aggregate detection is more pronounced with polyclonal as opposed to monoclonal antibody reagents. In addition, the nonionic detergent Triton X-100 does not hinder the detection of antigen-antibody aggregates at the concentrations used for permeabilization (15). Finally, we note that we are not advising that polyclonal anti-LC3 antibody reagents be avoided in autophagy studies. We are pointing out the optimal experimental conditions for their use in the detection of cytoplasmic puncta by confocal microscopy techniques.